Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI

被引:76
|
作者
Olsen, David B.
Gideon, Peter
Jeppesen, Tina Dysgaard
Vissing, John [1 ]
机构
[1] Natl Univ Hosp, Rigshosp, Dept Neurol, Sect 2082, DK-2100 Copenhagen, Denmark
[2] Natl Univ Hosp, Rigshosp, Dept Neuroradiol, DK-2100 Copenhagen, Denmark
关键词
gene fragment size; magnetic resonance imaging; facioscapulohumeral muscular dystrophy;
D O I
10.1007/s00415-006-0230-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Using MRI, we evaluated the degree of involvement of muscles in the lower extremities of 18 unselected patients with facioscapulohumeral muscular dystrophy (FSHD). Findings were correlated with fragment size of the mutated gene, age, disease duration and muscle power. Most affected muscles were the hamstrings followed by the tibialis anterior and the medial gastrocnemius. The vastus-, gluteal- and peroneal muscles were the most unaffected, and the psoas muscle did not show evidence of involvement in any of the investigated subjects. Asymmetric involvement was evident in 15% of the investigated muscles on MRI and 6% on manual muscle strength testing. MRI findings in muscle tended to correlate with disease duration (r = 0.49; p < 0.05), but not with gene fragment size or age. MRI disclosed involvement of muscles performing hip flexion and ankle dorsal flexion that could not be detected by manual muscle strength testing. Otherwise, there was a close correlation (approximate to r = 0.75; p < 0.0001) between muscle strength and MRI severity score for other muscle groups. The present study shows that MRI may disclose muscle involvement in FSHD that is not apparent on manual muscle testing, and suggests that MRI of muscle may be an important assessment tool in clinical trials involving patients with FSHD.
引用
收藏
页码:1437 / 1441
页数:5
相关论文
共 50 条
  • [41] Facioscapulohumeral muscular dystrophy
    Kress, W.
    Jakubiczka, S.
    Koch, M. C.
    MEDIZINISCHE GENETIK, 2009, 21 (03): : 337 - 341
  • [42] Muscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophy
    Hauerslev, S.
    Orngreen, M. C.
    Hertz, J. M.
    Vissing, J.
    Krag, T. O.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (03): : 194 - 201
  • [43] Inspiratory and expiratory muscle weakness in facioscapulohumeral muscular dystrophy
    Spiesshoefer, Jens
    Henke, Carolin
    Kabitz, Hans-Joachim
    Herkenrath, Simon
    Randerath, Winfried
    Brix, Tobias
    Young, Peter
    Boentert, Matthias
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [44] Facioscapulohumeral muscular dystrophy
    Tawil, Rabi
    NEUROTHERAPEUTICS, 2008, 5 (04) : 601 - 606
  • [45] Facioscapulohumeral muscular dystrophy
    Tawil, Rabi
    Van der Maarel, Silvere M.
    MUSCLE & NERVE, 2006, 34 (01) : 1 - 15
  • [46] Facioscapulohumeral Muscular Dystrophy
    Statland, Jeffrey
    Tawil, Rabi
    NEUROLOGIC CLINICS, 2014, 32 (03) : 721 - +
  • [47] Facioscapulohumeral muscular dystrophy
    Pospisilova, Jana
    Bjornara, Bard
    Bjornara, Kari Anne
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (04) : 364 - 364
  • [48] Facioscapulohumeral muscular dystrophy
    Fitzsimons, RB
    CURRENT OPINION IN NEUROLOGY, 1999, 12 (05) : 501 - 511
  • [49] Facioscapulohumeral muscular dystrophy
    Tawil R.
    Current Neurology and Neuroscience Reports, 2004, 4 (1) : 51 - 54
  • [50] Facioscapulohumeral muscular dystrophy
    van der Maarel, Silvere M.
    Frants, Rune R.
    Padberg, George W.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 186 - 194